XTX Topco’s CervoMed CRVO Stock Holding History

XTX Topco’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$152K	Buy	38,487 +28,180	+273%	+$147K	﹤0.01%	2943
2025 Q4	$81.4K	Buy	+10,307	New	+$82.8K	﹤0.01%	2692

Other funds holding CRVO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

XTX Topco's CRVO Position: Q1 2026 in Review

XTX Topco increased its CervoMed (CRVO) stake by 273% in Q1 2026, buying an estimated $147K and bringing the position to 38,487 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #2943.

XTX Topco first reported a position in CRVO in Q4 2025 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

XTX Topco held 38,487 shares of CervoMed worth $152K as of Q1 2026.
XTX Topco bought 28,180 CervoMed shares in Q1 2026, an estimated $147K.
CervoMed made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #2943 holding.
XTX Topco first reported a position in CervoMed in Q4 2025 and has held it in 2 quarters since.
36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.